/PRNewswire/ Medivir AB (NASDAQ: MVIR) (STOCKHOLM: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high.
IRLAB presents at Redeye Growth Day 30 May marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
28.05.2024 - a company discovering and developing novel treatments for Parkinson s disease - announces today that Gunnar Olsson, CEO, will present the company on Redeye Growth Day in Stockholm on Thursday, May 30. Gunnar Olsson, CEO of IRLAB, will give a short .
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.